By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioLineRx Ltd. 

19 Hartum Street
P.O. Box 45158
Jerusalem 91450      Israel
Phone: 972-2-548-9100 Fax: 972-2-548-9101



Company News
BioLineRx And I-Bridge Capital Establish A New Drug Development Joint Venture In China 8/25/2016 9:55:20 AM
BioLineRx Reports Second Quarter 2016 Financial Results 8/11/2016 8:21:29 AM
BioLineRx Names Philip A. Serlin As Chief Executive Officer 8/11/2016 7:03:30 AM
BioLineRx Signs Second Clinical Immuno-Oncology Collaboration Agreement To Investigate Combination Of BL-8040 And KEYTRUDA For Pancreatic Cancer 8/8/2016 7:47:13 AM
BioLineRx To Report Second Quarter Results On August 11, 2016 8/4/2016 12:46:59 PM
BioLineRx Announces In-Licensing Of Liver Fibrosis Project Under Strategic Collaboration 8/1/2016 8:06:18 AM
BioLineRx Announces Regulatory Submissions For Phase 2a Trial Of BL-8040 In Combination With KEYTRUDA (Pembrolizumab) For Treatment Of Pancreatic Cancer 6/28/2016 5:53:17 AM
BioLineRx To Present At The JMP Securities Life Sciences Conference In New York 6/16/2016 12:23:17 PM
BioLineRx's BL-8040 To Be Presented At Upcoming Scientific Conferences 5/19/2016 11:16:19 AM
BioLineRx Reports First Quarter 2016 Financial Results 5/17/2016 8:09:45 AM